Literature DB >> 21663467

Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females.

Benjamin Dieplinger1, Margot Egger, Werner Poelz, Christian Gabriel, Meinhard Haltmayer, Thomas Mueller.   

Abstract

BACKGROUND: Soluble ST2 (sST2) plasma concentrations are significantly higher in healthy men than in healthy women. The reason for the sex-specific difference of sST2 plasma concentrations is not established. The aim of this study was to evaluate the association of sST2 with sex-hormones in healthy males and females separately.
METHODS: We recruited 528 consecutive blood donors and measured plasma concentrations of sST2 and several sex-hormones (i.e., total testosterone, estradiol, sex hormone-binding globulin, follicle-stimulating hormone, and luteinizing hormone). Of the 528 blood donors, 338 were male and 190 were female. For data analysis, we further divided the group of females into the subgroups of pre- and postmenopausal women using the age of 50 years as a proxy for menopause.
RESULTS: In non-parametric Spearman's correlation analyses, we found a weak association between sST2 and total testosterone (r(s)+0.126, p=0.021) and also between sST2 and estradiol (r(s)+0.117, p=0.032) in males. In females <50 years of age (n=158) and ≥50 years of age (n=32), respectively, we did not detect any significant association between sST2 and sex-hormones. As a result of multiple linear regression analyses (calculated with log sST2 as dependent variable and log of age and all sex-hormones as explanatory variables), there was no independent association between sST2 and any of the sex-hormones neither in males nor in females.
CONCLUSIONS: In the present study cohort we did not find an independent association of sST2 with sex-hormones in healthy males and females. Therefore, the reason for the sex-specific difference of sST2 plasma concentrations still remains unclear.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21663467     DOI: 10.1515/CCLM.2011.239

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  11 in total

1.  Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis.

Authors:  Jessica C Garbern; Jason Williams; Amy C Kristl; Alyyah Malick; Inbal Rachmin; Benjamin Gaeta; Nafis Ahmed; Ana Vujic; Peter Libby; Richard T Lee
Journal:  J Mol Cell Cardiol       Date:  2019-02-11       Impact factor: 5.000

Review 2.  Cardiovascular biomarkers and sex: the case for women.

Authors:  Lori B Daniels; Alan S Maisel
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

Review 3.  Sexual Dimorphism in Cardiovascular Biomarkers: Clinical and Research Implications.

Authors:  Emily S Lau; Aleksandra Binek; Sarah J Parker; Svati H Shah; Markella V Zanni; Jennifer E Van Eyk; Jennifer E Ho
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 23.213

4.  Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study.

Authors:  Erin E Coglianese; Martin G Larson; Ramachandran S Vasan; Jennifer E Ho; Anahita Ghorbani; Elizabeth L McCabe; Susan Cheng; Michael G Fradley; Dana Kretschman; Wei Gao; George O'Connor; Thomas J Wang; James L Januzzi
Journal:  Clin Chem       Date:  2012-10-11       Impact factor: 8.327

5.  Elevated Sera sST2 Is Associated With Heart Failure in Men ≤50 Years Old With Myocarditis.

Authors:  Michael J Coronado; Katelyn A Bruno; Lori A Blauwet; Carsten Tschöpe; Madeleine W Cunningham; Sabine Pankuweit; Sophie van Linthout; Eun-Seok Jeon; Dennis M McNamara; Jan Krejčí; Julie Bienertová-Vašků; Erika J Douglass; Eric D Abston; Adriana Bucek; J Augusto Frisancho; Merci S Greenaway; Anneliese R Hill; Heinz-Peter Schultheiss; Leslie T Cooper; DeLisa Fairweather
Journal:  J Am Heart Assoc       Date:  2019-01-22       Impact factor: 5.501

Review 6.  Sex-Specific Cut-Offs for High-Sensitivity Cardiac Troponin: Is Less More?

Authors:  Giulio Francesco Romiti; Roberto Cangemi; Filippo Toriello; Eleonora Ruscio; Susanna Sciomer; Federica Moscucci; Marianna Vincenti; Clara Crescioli; Marco Proietti; Stefania Basili; Valeria Raparelli
Journal:  Cardiovasc Ther       Date:  2019-02-05       Impact factor: 3.023

7.  Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?

Authors:  Ashley M Miller; David Purves; Alex McConnachie; Darren L Asquith; G David Batty; Harry Burns; Jonathan Cavanagh; Ian Ford; Jennifer S McLean; Chris J Packard; Paul G Shiels; Helen Turner; Yoga N Velupillai; Kevin A Deans; Paul Welsh; Iain B McInnes; Naveed Sattar
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

8.  Soluble ST2 and Galectin-3: What We Know and Don't Know Analytically.

Authors:  Thomas Mueller; Benjamin Dieplinger
Journal:  EJIFCC       Date:  2016-08-01

Review 9.  Sex-related differences in contemporary biomarkers for heart failure: a review.

Authors:  Navin Suthahar; Laura M G Meems; Jennifer E Ho; Rudolf A de Boer
Journal:  Eur J Heart Fail       Date:  2020-03-27       Impact factor: 15.534

10.  Prognostic value of soluble ST2 in adults with congenital heart disease.

Authors:  Laurie W Geenen; Vivan J M Baggen; Annemien E van den Bosch; Jannet A Eindhoven; Judith A A E Cuypers; Maarten Witsenburg; Eric Boersma; Jolien W Roos-Hesselink
Journal:  Heart       Date:  2019-01-30       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.